Loading...
Dernières publications
-
Liem Nguyen, Maud Lemoine, Gibril Ndow, Zachary Ward, Timothy Hallet, et al.. Treat All versus targeted strategies to select HBV-infected people for antiviral therapy in The Gambia, west Africa: a cost-effectiveness analysis. The Lancet global health, 2024, 12 (1), pp.e66-e78. ⟨10.1016/S2214-109X(23)00467-9⟩. ⟨pasteur-04363873⟩
-
Luc Jaulmes, Youri Yordanov, Alexandre Descamps, Isabelle Durand-Zaleski, Aurélien Dinh, et al.. Effectiveness and Medicoeconomic Evaluation of Home Monitoring of Patients With Mild COVID-19: Covidom Cohort Study. Journal of Medical Internet Research, 2023, 25, pp.e43980. ⟨10.2196/43980⟩. ⟨hal-04142340⟩
-
Christiana Kartsonaki, J Kenneth Baillie, Noelia García Barrio, Joaquín Baruch, Abigail Beane, et al.. Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19. International Journal of Epidemiology, 2023, 52 (2), pp.355-376. ⟨10.1093/ije/dyad012⟩. ⟨hal-04164628⟩
-
Paul Loubet, Linda Wittkop, Laetitia Ninove, Mathieu Chalouni, Benoit Barrou, et al.. One-month humoral response following two or three doses of mRNA Covid-19 vaccines as primary vaccination in specific populations in France: first results from the ANRS0001S COV-POPART cohort. Clinical Microbiology and Infection, 2023, 29 (3), pp.388.e1-388.e8. ⟨10.1016/j.cmi.2022.10.009⟩. ⟨hal-03822592⟩
-
Jade Ghosn, Delphine Bachelet, Marine Livrozet, Minerva Cervantes-Gonzalez, Julien Poissy, et al.. Prevalence of Post-Acute COVID-19 Symptoms Twelve Months after Hospitalisation in Participants Retained in Follow-up: Analyses Stratified by Gender from a Large Prospective Cohort. Clinical Microbiology and Infection, 2023, 29 (2), pp.254.e7-254.e13. ⟨10.1016/j.cmi.2022.08.028⟩. ⟨hal-03801797⟩
Le CIC-1417 sur Twitter
Documents en texte intégral
70
Notices
67
Mots clés
Vaccines
Calcium phosphorus evaluation
Clinical practice
Clinical research
Healthcare workers
Deletion
Déterminants
Disinformation
Acute kidney injury
Incidence
Vaccine
DMD
Catch-up
EMA
Vaccine safety and efficacy
Cancer
Adjuvant
CERVICOVAGINAL SECRETIONS
Confidence
Internet
Elderly
AIDS
COVID-19 vaccines
Adverse effects
Booster response
Risk factors
Determinants
Covid 19
1790GAHB F
AON
Digital care
Alpha variant
Practices
Dialysis
Drug
ANTIRETROVIRAL THERAPY
Immunocompromised
Effectiveness
Determinant
Covidom
Delphi study
Diabetes mellitus type 2
Chemotherapy
Influenza
Biomarkers
Epidemiology
Misinformation
Cost of illness
Antiviral
Attitudes
Co-morbidities
HIV
EHealth literacy
SARS-CoV-2
Sleep
Data sharing
Care management
Innate immunity
Immunization
Efficacy
Clinical skills
Chronic kidney disease
Vaccine acceptance
Coadministration
COVID-19
Adults
Respiratory syncytial virus
C-type lectin receptor
Antiviral agents
HPV vaccine
Dose escalation
Antiviral therapy
Coronavirus
Awareness
Conjugate pneumococcal vaccine
Dendritic cells
COCONEL cohort surveys
Attitude to health
Attitude
Vaccine effectiveness
Adenoviral vector
Antiretroviral therapy
Assay
Clinical trials
Boys
Conditional marketing authorization
Attitudes of health personnel
Cohort
Cohort study
Influenza-like illness
Vaccine hesitancy
AstraZeneca vaccine
Covid-19
B-lymphocytes
France
Digital health intervention
Cystic fibrosis
Vaccination
Immunogenicity
Hesitancy